Oral Cancer : Pharmacology

Oral Cavity Cancer is associated with high incidence of loco-regional recurrences, which account for the majority of treatment failures post-surgery and radiotherapy. The time-course of relapse manifestation and metastasis are unpredictable. Relapsed OCC represents a major clinical challenge in part due to their aggressive and invasive behaviors. Chemotherapy remains the only option for advanced OCC whenever salvage surgery or re-irradiation is not feasible, but its efficacy is limited as a result of the drug resistance development. Alternatives to use of different permutations of standard cytotoxic drugs or combinations with modulators of drug resistance have led to incremental therapeutic benefits. The introduction of targeted agents and biologics against selective targets that drive cancer progression has opened-up optimism to achieve superior therapeutic activity and overcome drug resistance because, unlike the non-selective cytotoxic, the target can be monitored at molecular levels to identify patients who can benefit from the drug. This review discusses the multifactorial aspects of clinical drug resistance and emerging therapeutic approaches in recurrent OCC, emphasizing recent advances in targeted therapies, immunotherapy, and potential relevance of new concepts such as epithelial-mesenchymal transition and cancer stem cell hypothesis to drug resistance.

    Related Conference of Oral Cancer : Pharmacology

    March 12-14, 2018

    Global Summit on Oncology & Cancer

    Singapore
    May 24-25, 2018

    22nd Global Annual Oncologists Meeting

    Osaka, Japan
    June 1-2, 2018

    Global Meeting on Oncology and Radiology

    Osaka,Japan
    July 02-03, 2018

    World Cancer Summit 2018

    Thailand, Bangkok
    July 16-17, 2018

    8th World Congress on Breast Cancer & Therapies

    Melbourne, Australia
    July 18-19, 2018

    4th Annual Conference on Preventive Oncology

    Atlanta, Georgia, USA
    July 23-24, 2018

    Experts Meet On Cancer Therapy 2018

    Melbourne, Australia
    August 02-03, 2018

    Global Biomarker Summit

    | Oslo, Norway
    September 5-6, 2018

    15th Asia Pacific
    Oncologists Annual Meeting

    Tokyo, Japan
    August 09-10, 2018

    28th Euro Congress on Cancer Science & Therapy

    Madrid, Spain
    Aug 27-28, 2018

    20th World Congress on Radiology

    Toronto, Canada
    September 17-18, 2018

    International Conference on Oncogenesis and Oncologic Emergency Medicine

    San Diego, California, USA
    September 17-18, 2018

    28th International Conference on Cancer Research and Anticancer Therapies

    San Diego, California, USA
    September 20-21, 2018

    3rd Cancer Diagnostics Conference & Expo

    Berlin, Germany
    September 27-28, 2018

    3rd World Conference on Breast and Cervical Cancer

    | Abu Dhabi, UAE
    October 03-04, 2018

    2nd International Conference on Cancer Biology and Drug Delivery

    Los Angeles, California, USA
    October 03-04, 2018

    12th World Congress on Biomarkers & Clinical Research

    Los Angeles, California, USA
    October 15-16, 2018

    22nd World Conference onLiquid Biopsy & Biomarkers

    Toronto, Canada
    October 18-19, 2018

    Euro Oncology Summit

    | Amsterdam, Netherlands
    October 18-19, 2018

    Euro Breast Cancer Summit

    | Amsterdam, Netherlands
    October 11-13, 2018

    36th World Cancer Conference

    Zurich, Switzerland
    October 26-27, 2018

    International Conference on Robotic Oncology

    Osaka, Japan
    October 29-30, 2018

    International Conference on Gastrointestinal Cancer and Therapeutics

    San Francisco, California, USA
    October 29-30, 2018

    26th Annual Congress on Cancer Science and Targeted Therapies

    San Francisco, California, USA
    December 07-08, 2018

    27th World Oncologists Annual Conference

    Chicago, Illinios, USA

    Oral Cancer : Pharmacology Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in